Biggest News Aggregation in the World
📰 Eb Developer News

Page 65 - Eb Developer News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Eb Developer. Real-time updates on events, politics, business and more.

VinFast launched VF 3, VF 6, VF 7 and electric bikes in Vietnam

<p>HANOI, VIETNAM - <a href="https://www.media-outreach.com">Media OutReach</a> - 7 July 2023 -<i> </i><a href="https://vinfastauto.com/"><b><i>VinFast</i></b></a><i> officially launched three new electric car models including VF 3, VF 6, VF 7, and its first e-bike models in Vietnam.</i></p>
Han I Republic Of Nguyen Viet Quang Torino Design Voice Assistant Greener Future

PU Prime Launches Demo Trading Contest

<div> <ul> <li> PU Prime is taking a fresh approach to the traditional trading contest with futuristic visuals and an exciting theme, making it well-suited for beginner traders as it is also risk-free trading done on a demo account </li> <li> Prizes incentivize traders to do well by strategising their trading, inculcating good habits when they start trading with a live account </li> <li> Also gives experienced trad...
Cosmic Trading Battle Royale Olive Account Original Link Mobile Reviews Market Research Cloud Computing

ROSEN, LEADING INVESTOR COUNSEL, Encourages DouYu International Holdings Limited Investors to Secure Counsel Before Important Deadline in the Securities Class Action First Filed by the Firm

<p>New York, New York - <a href="https://www.newsfilecorp.com/">Newsfile Corp.</a> - July 6, 2023 - <b>WHY: </b>Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of DouYu International Holdings Limited (NASDAQ: DOYU) between April 30, 2021 and May 9, 2023, both dates inclusive (the "Class Period") of the important<b> August 8, 2023 lead plaintiff deadline</b> in the securities class action first...
New York United States Phillip Kim Laurence Rosen Chinese Company Newsfile Corp

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases

<ul> <li> Secarnas LNAplus™ ASOs suppress expression of NLRP3, a central component of the inflammasome pathway, which is overactive in many inflammatory diseases </li> <li> Cryopyrin-associated periodic syndrome (CAPS) is a group of rare inherited autoinflammatory diseases driven by overactive NLRP3, resulting in systemic inflammation </li> <li> With NLRP3-specific ASOs, inflammatory downstream effects were interrupted in immune cells a...
Frank Jaschinski Ariel Feldstein Secarna Lnaplus Hal Hoffman Secarna Pharmaceuticals Secarna Pharmaceuticals Gmbh Co

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science